About HP Inc. HP Inc. (NYSE: HPQ) is a global technology leader redefining the Future of Work. Operating in more than 180 countries, HP delivers innovative and AI-powered devices, software, services, ...

Tribesigns, a global furniture designer and manufacturer, announced its participation in TikTok's SOHO CHIC Lifestyle campaign, a Fall 2026 home-living initiative that explores how urban character, ...

Engineering for a better life. On October 12, the 91st Paris Motor Show opened at Paris Expo Porte de Versailles. GAC presented new energy vehicles from its three brands, with the AION UT Cross making ...

In Europe, GAC is bringing not only high-quality products, but also consistent service standards tailored to local users. At the show, GAC officially launched GAC CARE+, guided by the service ...

Developed by the GAC Milan Design Center, AION UT Cross is a light off-road crossover EV that combines hatchback agility, wagon-like space and SUV-level capability. Its stylish design and exclusive ...

GAC is strengthening its presence in Europe through engineering excellence. In R&D and design, the GAC Milan Design Center combines forward-looking European design with global aesthetics, while the ...

Bitmine owns 4.9% of the total ETH coin supply of 122.1 million. Bitmine is 99% of the way to the 'Alchemy of 5%' in just 15 ...

GEP Global Supply Chain Volatility Index — a leading indicator tracking demand conditions, shortages, transportation costs, inventories and backlogs, based on a monthly survey of 27,000 businesses — ...

And GTCPrime Chief Analyst, Jameel Ahmad, also took part in a panel discussion, "The Future of Wealth Is East: Why Hong Kong ...

PRNewswire/ -- oneworld ® is taking the next step toward simplifying the online travel experience across its global network for customers travelling on multi-carrier journeys. Now available on all ...

MiTAC Computing Technology Corporation, a subsidiary of MiTAC Holdings Corporation (TWSE: 3706) and a global leader in high-performance server solutions, today unveiled its latest AI infrastructure ...

This is the second Phase 2 study of MT027 to receive FDA clearance. MT027 was previously cleared by the FDA to proceed with a Phase 2 study in recurrent glioblastoma, and has been granted Orphan Drug ...